Basic Urologic Ultrasound (2022)

The use of ultrasound is fundamental to the practice of urology. Urologists use ultrasound daily in the office and in the surgical setting to diagnose urologic disease and to guide treatment. In order for urologists to achieve the best possible outcomes from this technology they must have a thorough understanding of the physical principles of ultrasound, the principles of image generation and the common artifacts associated with ultrasound. By viewing this online video, urologists will become acquainted with the effects of technique and machine adjustments on image quality. Documentation of an ultrasound procedure using accepted conventions for orientation, content and nomenclature will be demonstrated. Patient safety implications of the bioeffects of ultrasound will be emphasized. This online video is the foundation for urologic ultrasound education.

The Basic Urologic Ultrasound 2011 online video covers the physical principles of ultrasound, technique, machine settings, documentation and safety of urologic ultrasound. Emphasis on the physics of ultrasound, patient safety considerations and the limitations and advantages of ultrasound are some of the topics that will be addressed.

Target Audience

  • Urologists
  • Urology Residents

Learning Objectives

After participating in this activity, the learner should be able to:

  1. Identify the physical principles of ultrasonography
  2. Analyze the effect of technique and machine adjustment on image quality
  3. Classify commonly seen artifacts based on underlying physical principles
  4. Employ accepted conventions for the documentation of an ultrasound exam
  5. Associate the modes of ultrasound with their appropriate application
  6. Identify the patient safety implications of the bioeffects of ultrasound
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Course opens: 
Course expires: 


Pat F. Fulgham, MD
Surgical Director of Oncology
Department of Urology
Presbyterian Hospital of Dallas
Dallas, TX
Disclosures: Urology Clinics of North Texas: Other


Urologic Diagnostic & Therapeutic Imaging Committee (UDTIC) Members' Disclosures

Pat F. Fulgham, MD
Dallas, TX
Disclosures: Urology Clinics of North Texas: Other

Ronney Abaza, MD
Columbus, OH
Disclosures: Nothing to disclose

Dean G. Assimos, MD
Winston-Salem, NC
Disclosures: Med Review in Urology: Board Member, r, Trustee; National Institute of Health (NIH): Investigator; Oxalosis and Hyperoxaluria Foundation (OHF): Consultant or Advisor; Piedmont Stone: Other; Urology Times: Board Member, Officer, Trustee

Jay T. Bishoff, MD
Salt Lake City, UT
Disclosures: Pfizer: Meeting Participant of Lecturer

Patrick N. Ciccone, MD
Belleville, NJ
Disclosures: Nothing to disclose

Ralph V. Clayman, MD
Irvine, CA
Disclosures: Applied Urology: Investment Interest; Boston Scientific: Other; Cook Urological: Consultant or Advisor; Greenwald Inc: Other; Orthopedic Services Inc (OSI): Other; Vascular Technology Inc: Other

John M. Corman, MD
Seattle, WA
Disclosures: Amgen: Investigator; Astra Zeneca: Investigator; Dendreon: Investigator; Epigenomics: Investigator; Glaxo Smith Kline: Investigator; Roll International: Investigator; Wilex: Investigator

Bruce R. Gilbert, MD, PhD
Great Neck, NY
Disclosures: Auxilium: Investigator; Bayer Healthcare Pharmaceuticals Inc: Investigator; Warner Chilcott: Investigator

Frederick A. Gulmi, MD
Brooklyn, NY
Disclosures: Brooklyn Urologic Research Group: Board Member, Officer, Trustee

Gary M. Kirsh, MD
Loveland, OH
Disclosures: Amgen: Consultant or Advisor; Core Oncology: Consultant or Advisor

Kevin R. Loughlin, MD
Boston, MA
Disclosures: Certus Biomedical: Consultant or Advisor; Predictive Biosciences: Board Member, Officer, Trustee; Sierra Molecular: Consultant or Advisor; Taris: Consultant or Advisor; Tengion: Consultant or Advisor

Peter S. Lund, MD
Erie, PA
Disclosures: Pennsylvania Medical Society: Board Member, Officer, Trustee

Arturo Mendoza-Valdes, MD
Disclosures: Bristol Myers: Scientific Study or Trial; Ferring: Scientific Study or Trial;TAKEDA-MILLENIUM: Investigator

Steven M. Schlossberg, MD
New Haven, CT
Disclosures: Nothing to disclose

Richard Scott
Linthicum, MD
Disclosures: Nothing to disclose

Stephanie Stinchcomb, CPC
Linthicum, MD
Disclosures: Accurate Coding Solutions: Consultant or Advisor; Board of Medical Specialty Coding: Consultant or Advisor

Martha K. Terris, MD
Augusta, GA
Disclosures: Nothing to disclose

Edouard J. Trabulsi, MD
Philadelphia, PA
Disclosures: Amgen: Consultant or Advisor; Centocor: Consultant or Advisor; Intuitive Surgical: Consultant or Advisor; Lantheus Medical Imaging: Scientific Study or Trial

Education Council

Elspeth M. McDougall, MD
Orange, CA
Disclosures: Endocare: Other; Ethicon Endo-Surgery: Other; Intuitive Surgical: Other; Karl Storz Endoscopy America: Other;Â Simbionix: Other

Christopher L. Amling, MD
Portland, OR
Disclosures: Sanofi-Aventis: Meeting Participant or Lecturer

Gopal Badlani, MD
Winston-Salem, NC
Disclosures: Allergan: Investigator; Lithotripsy Group: Piedmont Stone & Physician Discovery: Investment Interest; Olympus: Investigator; Pfizer: Investigator

Peter R. Carroll, MD
San Francisco, CA
Disclosures: Abbott Pharmaceuticals: Investigator; Department of Defense: Investigator;Â NIH: Investigator

Marc S. Cohen, MD
Gainesville, FL
Disclosures: Nothing to disclose

Robert C. Flanigan, MD
Clarendon Hills, IL
Disclosures: National Cancer Institute: Investigator; NIDDK (NIH): Consultant or Advisor; WJ Weiser: Family/Employee/Affiliation

Pat F. Fulgham, MD
Dallas, TX
Disclosures: Urology Clinics of North Texas: Other

Bruce R. Gilbert, MD, PhD
Greatneck, NY
Disclosures: Auxillum: Investigator; Bayer Healthcare Pharmaceuticals Inc: Investigator; Warner Chilcott: Investigator

David F. Jarrard, MD
Madison, WI
Disclosures: Johnson and Johnson: Consultant or Advisor

David B. Joseph, MD
Birmingham, AL
Disclosures: Center for Disease Control and Prevention: Investigator; Spina Bifida Foundation: Board Member, Officer, Trustee; Tengion: Scientific Study or Trial

Barry A. Kogan, MD
Albany, NY
Disclosures: Nothing to disclose

Benjamin R. Lee, MD
New Orleans, LA
Disclosures: Cook Urological: Consultant or Advisor

Fray F. Marshall, MD
Atlanta, GA
Disclosures: Nothing to disclose

Mary Mathe, PA-C
Celebration, FL
Disclosures: Aureon: Consultant or Advisor

Badar M. Mian, MD
Albany, NY
Disclosures: Nothing to disclose

Arthur P. Mourtzinos, MD
Burlington, MA
Disclosures: Allergan: Investigator; American Medical Systems: Consultant or Advisor; Astellas: Meeting Participant or Lecturer; Coloplast: Meeting Participant or Lecturer; Johnson & Johnson: Consultant or Advisor

J. Kellogg Parsons, MD
LaJolla, CA
Disclosures: AMS: Meeting Participant or Lecturer; Aureon: Consultant or Advisor

Jaspreet S. Sandhu, MD
New York, NY
Disclosures: American Medical Systems: Consultant or Advisor

William D. Steers, MD
Charlottesville, VA
Disclosures: Allergan: Scientific Study or Trial; Food and Drug Administration: Consultant or Advisor; National Institutes of Health: Consultant or Advisor; New England Research Institute (NERI): Consultant or Advisor

John T. Stoffel, MD
Burlington, MA
Disclosures: Nothing to disclose

Chandru P. Sundaram, MD
Indianapolis, IN
Disclosures: Nothing to disclose

Robert M. Sweet, MD
Minneapolis, MN
Disclosures: Allergan: Scientific Study or Trial; American Medical Systems Holding, Inc: Scientific Study or Trial; Coruthers Health Consulting: Consultant or Advisor; Gyrus ACMI Olympus: Other; Medtronic: Scientific Study or Triall; Red Llama Incorporated: Owner

Zhou Wang, PhD 
Pittsburgh, PA
Disclosures: Nothing to disclose

Alan J. Wein, MD, PhD
Disclosures: Allergan: Consultant or Advisor; Astellas: Consultant or Advisor; ENDO Pharmaceuticals: Consultant or Advisor; Medtronic: Consultant or Advisor; Pfizer: Consultant or Advisor

Administrative Staff

Angela Clark
Dallas, TX
Disclosures: Nothing to disclose

Denise Williams
Linthicum, MD
Disclosures: Nothing to disclose

2016 Reviewer

Peter Knapp, MD
Disclosures: Strand Diagnostics: Consultant or Advisor

2019 Reviewer

Timothy McClure, MD
Disclosures: Nothing to disclose

2022 Reviewer

Pat F. Fulgham, MD
Disclosures: Urology Clinics of North Texas: Other



To claim credits/hours of participation, participants must view the online video, take the online posttest, passing with a score of at least 80%, complete and submit the evaluation.


The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The American Urological Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.


It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.


All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.


All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:

  • Peer review for valid, evidence-based content by the AUA COI Review Work Group. 
  • Attestation that clinical recommendations are evidence-based and free of commercial bias.
  • Introduction of a debate format (point-counterpoint)
  • Inclusion of moderated panel discussion with unbiased moderator
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Divestiture of the relationship by faculty
  • Recusal from controlling relevant aspects of planning 
  • Selection of alternative faculty for specific topic


The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.



 The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.


Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.


The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.


Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.


The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.


May 2011


This activity was peer reviewed July 2014, August 2016, January 2019, and February 2022.


March 2025



Materials contained within this video are the sole property of the American Urological Association Education and Research, Inc. and may not be copied or duplicated without the written permission of the American Urological Association Education and Research, Inc.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Please login or register to take this course.